Skip to content

Research on Intelligent Rehabilitation Technology Based on Wearable Devices

Research on Intelligent Rehabilitation Technology Based on Wearable Devices

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104493
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, craniocerebral injury, brain tumor

Interventions

Observation group:None

Sponsors

General Hospital of the People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with stroke, traumatic brain injury, brain tumors, etc., within 90 days by CT or MRI; (2) Aged between 30 and 75 years old, regardless of gender; (3) Rehabilitation patients with limb motor dysfunction (Brunnstrom stage II to VI for upper and/or lower limbs in hemiplegia motor function assessment) within 180 days after onset, with stable condition; (4) Clear cognition, able to follow the research protocol; (5) The subjects understand the purpose of the study, demonstrate sufficient compliance with the research protocol, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Significant cognitive or consciousness impairments that prevent the completion of the Fugl-Meyer scale assessment; (2) Other significant limb pathologies, such as fractures, severe arthritis, amputations, etc.; (3) Formation of joint contractures in limbs; (4) Patients with legal disabilities, such as blindness, deafness, muteness, intellectual disabilities, mental disorders, or physical disabilities; (5) Patients with severe primary diseases of the cardiovascular, liver, kidney, and hematopoietic systems, or those with psychiatric disorders; (6) Fertile women with positive urine pregnancy test results; (7) Individuals who have participated in other drug/device clinical research within 90 days prior to screening; (8) Individuals carrying active metal devices internally, such as pacemakers, etc.; (9) Other individuals deemed by the researchers as unsuitable for participation in this trial.

Design outcomes

Primary

MeasureTime frame
Fugl-meyer assessment score;

Secondary

MeasureTime frame
The determination coefficient between Fugl-Meyer intelligent assessment and actual assessment;Accuracy of activity recognition;

Countries

China

Contacts

Public ContactLv Ming; Cheng Gang

General Hospital of the People's Liberation Army of China

yxgcbj@163.com+86 186 1163 7702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026